<DOC>
	<DOCNO>NCT01250340</DOCNO>
	<brief_summary>In individual Type 2 Diabetes ( T2D ) obtain outstanding improvement management hyperglycemia , achieve similar result reduction atherosclerotic syndrome . The comprehension mechanism link nutrition inflammation innate immune response important understand relationship insulin resistance , diabetes mellitus endothelial dysfunction . It investigate : 1 ) role Toll Like Receptors ( TLR ) pathophysiology T2D associate atherosclerosis ; 2 ) role aspirin nicotinamide adenine dinucleotide phosphate ( NADPH ) oxidase inhibitor/s production TxA2 F2-isoprostanes T2D patient ; 3 ) new biomarkers associate Diabetes atherosclerosis include marker endothelial dysfunction cytokine . It analyze isolated platelet normal control and/or diabetic patient production TxA2 , isoprostanes pro-inflammatory/thrombotic cytokine use aspirin NADPHoxidase inhibitor .</brief_summary>
	<brief_title>Type 2 Diabetes Mellitus Atherosclerosis</brief_title>
	<detailed_description>Study design : prospective , control , randomize study . All eligible patient randomly assign 1:1 manner receive aspirin placebo . In recruited subject : 1 . Anamnestic clinical information Anthropometric measurements 2 . Electrocardiogram , echocardiogram ultrasound assessment carotid intima-media thickness ( IMT ) flow-mediated dilatation ( FMD ) 3 . Ankle-Brachial Index measurement ( ABI ) 4. blood sample antecubital vein overnight fast urine sample baseline , 3 day 30 day aspirin ( 100 mg/day ) administration . Laboratory Methods : Blood sample immediately centrifuge 2,000 rpm 20 min 4°C , supernatant collect stored -80°C measurement . All measurement do blind . Samples test duplicate , show value standard curve re-tested appropriate dilutions.Analysis urinary platelet isoprostane : Urinary PGF2α-III measure previously describe validated EIA assay method . Ten millilitre urine extract C-18 SPE column ; purification test recovery add radioactive tracer ( tritiated PGF2α-III ) ( Cayman chemical ) . The eluate dry nitrogen , recover 1ml buffer , assay PGF2α-III specific EIA kit ( Cayman chemical ) . Urinary PGF2α-III concentration correct recovery creatinine excretion express pg/mg creatinine . PRP centrifuge 20 min 800 g concentrate platelet pellet suspend Tyrode buffer obtain final platelet concentration 5x108/mL . PGF2α-III content measure validated EIA assay method previously describe express pg/mg platelet protein .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Type 2 Diabetes Mellitus ( define accord criterion American Diabetes Association ) Sign write informed consent participate interventional study Liver disease Serious renal disorder ( serum creatinine &gt; 2.5 mg/dL ) History evidence previous major vascular event ( myocardial infarction , transient ischemic attack , stroke ) History major bleed Autoimmune disease Cancer present recent infection Use nonsteroidal antiinflammatory drug , drug interfere cholesterol metabolism , vitamin supplement antiplatelet drug previous 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Isoprostanes</keyword>
	<keyword>Thromboxane</keyword>
	<keyword>Aspirin</keyword>
</DOC>